Compare ALMR & BGSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ALMR | BGSI |
|---|---|---|
| Founded | N/A | 1990 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | |
| Sector | Industrials | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 2.4B |
| IPO Year | 2026 | 2025 |
| Metric | ALMR | BGSI |
|---|---|---|
| Price | $28.61 | $88.34 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $157.00 |
| AVG Volume (30 Days) | ★ 261.2K | 34.5K |
| Earning Date | N/A | 05-13-2026 |
| Dividend Yield | N/A | ★ 0.38% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $35.07 |
| Revenue Next Year | N/A | $8.01 |
| P/E Ratio | ★ N/A | $231.07 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $21.58 | $81.39 |
| 52 Week High | $38.54 | $183.10 |
| Indicator | ALMR | BGSI |
|---|---|---|
| Relative Strength Index (RSI) | 41.84 | 50.91 |
| Support Level | $23.69 | $88.97 |
| Resistance Level | $28.35 | $99.16 |
| Average True Range (ATR) | 1.94 | 3.23 |
| MACD | -0.69 | 0.75 |
| Stochastic Oscillator | 9.57 | 95.24 |
Alamar Biosciences Inc is a proteomics company engaged in protein detection and analysis. The company has developed its own NULISA (NUcleic Acid Linked Immuno-Sandwich Assay) technology as the foundation of its Precision Proteomics platform enabling the detection and quantification of protein biomarkers in a single sample with ultra-high sensitivity and high specificity, even from very small volumes of biofluid. The company operates in single segment and focuses on developing a good sensitive proteomic liquid biopsy platform and sells instruments, consumables, and services based on this platform to enable early detection of diseases. The products of the company includes NULISAseq Panels, NULISAqpcr Assays, and others.
Boyd Group Services Inc is engaged in operating non-franchised collision repair centers in North America. The Company's primary line of business is automotive collision and glass repair and related services, with the majority of revenues relating to this group of similar services. This line of business operates in Canada and the U.S. and both regions exhibit similar long-term economic characteristics. The Company is also a retail auto glass operator in the United States, under the trade names Gerber Collision & Glass, Glass America, Auto Glass Service, Auto Glass Authority. The company has majority of its sales from USA.